MWNA
STIM icon

Marshall Wace North America’s Neuronetics STIM Stock Holding History

Marshall Wace North America’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-66,839
Closed -$827K – 1760
2021
Q1 		$827K Buy
+66,839
New +$1.02M ﹤0.01% 1091
2018
Q3 		– Sell
-15,574
Closed -$414K – 1344
2018
Q2 		$414K Buy
+15,574
New +$424K ﹤0.01% 1118

Other funds holding STIM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Marshall Wace North America's STIM Position: Q2 2021 in Review

Marshall Wace North America sold out of Neuronetics (STIM) in Q2 2021, closing a stake of 66,839 shares — an estimated $827K sold.

Marshall Wace North America first reported a position in STIM in Q2 2018 and held it in 2 quarters. The position peaked at $827K in Q1 2021. 105 funds tracked by Wall St. Rank hold STIM as of Q2 2021.

  • Marshall Wace North America reported no remaining Neuronetics position as of Q2 2021 after selling out during the quarter.
  • Marshall Wace North America sold 66,839 Neuronetics shares in Q2 2021, an estimated $827K.
  • Marshall Wace North America first reported a position in Neuronetics in Q2 2018 and held it in 2 quarters.
  • Marshall Wace North America's Neuronetics position peaked at $827K in Q1 2021.
  • 105 funds tracked by Wall St. Rank held Neuronetics as of Q2 2021.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.